
Cooking up food in the office microwave? New study reveals shocking amount of bacteria
A study about office microwaves may have some people rethinking their leftovers for lunch.
Researchers examined the differences in bacteria present in domestic spaces such as a home; in shared-domestic spaces such as an office; and in laboratories.
The study, conducted by researchers in Valencia, Spain, and published in Frontiers in Microbiology, discovered over 100 species of bacteria exist within these spaces – with most of the bacteria being the types found on human skin.
Some of these bacteria can cause foodborne illnesses.
Fox News Digital spoke with Christine Schindler, the New York City-based CEO and co-founder of PathSpot, a health and safety operating system for restaurants and businesses that prepare and serve food, about the difference between at-home and in-office appliances.
"The setting of a microwave fundamentally changes its contamination profile," she told Fox News Digital.
"People rush through lunch breaks, sometimes skipping proper hand hygiene, touching communal surfaces like refrigerator handles before accessing the microwave," she added.
In shared environments like this, microwaves can become bacterial transfer points, she said.
These different bacteria can come from human skin, food splatter and moisture build-up.
Microwaves can become bacterial transfer points.
The presence of bacteria can cause stomach problems such as nausea and vomiting – and the risk increases through the "food-handling sequence," according to Schindler.
"Bacterial risk isn't just about what grows in the microwave – it's about how bacteria move between hands, surfaces and food in a continuous cycle," Schindler said.
Something else the researchers sought to understand is whether microwave radiation has a sterilizing effect on food or if exposure to a wide variety of food and humans had more impact on cleanliness.
"Microwaves kill bacteria in food through heat, not the actual microwaves themselves," Schindler clarified.
"However, this heating doesn't clean the microwave itself or address the bacteria on handles and buttons from unwashed hands," she said.
"This creates a shared responsibility in food safety – you need both properly cooked food and clean microwave surfaces to break the contamination cycle."
The researchers said that what they found "suggests the importance of regular cleaning practices to mitigate potential health risks, as frequent and adequate cleaning with appropriate disinfectants helps to prevent the presence of pathogens associated with these domestic environments."
At home, you're typically dealing with a known group of users and established cleaning routines, something Schindler said makes the difference in maintaining a hygienic environment.
"Office break rooms create more opportunities for bacterial spread," she said. "More users means more hand-to-surface contamination, often less personal accountability for cleaning and greater diversity of foods being heated."
There are some simple ways to keep microwaves clean, even in the office.
Schindler said to wipe down these high-touch areas regularly with food-safe disinfectants, especially in shared kitchens where many people use the same appliance.
For those with more time to spare, she said, heating a bowl of water with lemon juice can loosen up any gunk inside the microwave, making removal easier.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
PepGen Inc. (PEPG) Halts DMD Program After Trial Miss; Shifts Focus to DM1
Boston-based biotech PepGen Inc. (NASDAQ:PEPG) announced today it will discontinue all Duchenne muscular dystrophy (DMD) research after its lead candidate, PGN-EDO51, failed to achieve target dystrophin levels in the CONNECT1-EDO51 trial. Despite being well tolerated at 10 mg/kg, PGN-EDO51 only increased dystrophin to 0.59% of normal levels, falling short of expectations. All treatment-related adverse events were mild, and no serious events were reported. A healthcare professional in a meeting with a patient discussing care options using digital technology. 'We are disappointed by the results and will wind down our DMD program,' said CEO James McArthur, PhD, thanking patients and staff for their support. PepGen Inc. (NASDAQ:PEPG) will now focus on its promising myotonic dystrophy type 1 (DM1) program, PGN-EDODM1, which has shown robust target engagement and a favorable safety profile. PepGen Inc. (NASDAQ:PEPG) expects data from its Phase 1 FREEDOM-DM1 trial's 15 mg/kg cohort in the second half of 2025, and from the Phase 2 FREEDOM2-DM1 5 mg/kg cohort in early 2026. PGN-EDODM1, which has Orphan Drug and Fast Track status, targets the genetic root of DM1, a rare, life-shortening disorder with no approved treatments. While we acknowledge the potential of PEPG to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PEPG and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Smoking marijuana and eating cannabis gummies both linked to dangerous health risk, study finds
Long-term cannabis use in any form has been linked to a greater risk of heart disease. In a new study, researchers at UC San Francisco determined that eating edible cannabis, such as gummies, has the same impact on cardiovascular risk as smoking marijuana. The risk stems from reduced blood vessel function, according to the study, which was published in JAMA Cardiology on May 28. Heavy Cannabis Use Could Pose This Threat To The Brain The study included 55 people between 18 and 50 years of age who were "outwardly healthy." The participants were divided into three groups: those who regularly smoked marijuana, those who ate edibles containing THC (tetrahydrocannabinol), and those who didn't use cannabis, according to a UCSF press release. Read On The Fox News App The cannabis users had been consuming the substance at least three times weekly for at least one year. On average, the smokers had the habit for 10 years, while those consuming edibles had been doing so for five years, the release noted. In September 2024, the participants underwent testing to determine how well their blood vessels functioned and whether the cells lining the blood vessels were affected. Dementia Risk Connected To Cannabis-related Hospital Visits, Says Study All cannabis users were found to have "decreased vascular function," comparable to those who smoke tobacco. Their blood vessel function was roughly half compared to those who did not use cannabis. This side effect has been linked to a higher risk of heart attack, high blood pressure and other cardiovascular conditions, the researchers noted. The participants who smoked marijuana were also found to have changes in their blood serum that harmed cells lining their blood vessels and lymphatic vessels, an effect that was not seen in those who ate edible cannabis. The researchers noted that while smoking marijuana and consuming edibles both affect vascular function, they likely do so for different reasons. Shingles Vaccine Has Unexpected Effect On Heart Health "Chronic cannabis smoking and THC ingestion were associated with endothelial dysfunction [impaired functioning of the endothelial cells lining the inside of blood vessels] similar to that observed in tobacco smokers, although apparently occurring via distinct mechanisms," the researchers wrote. "This study enhances the understanding of the potential risks to vascular health linked to cannabis use and provides more evidence that cannabis use is not benign." Dr. Bradley Serwer, a Maryland-based cardiologist and chief medical officer at VitalSolution, an Ingenovis Health company that offers cardiovascular and anesthesiology services to hospitals nationwide, said he was not surprised by the study's findings. "We have known that the chronic use of THC-containing compounds can have negative health consequences — this study just reaffirms those prior studies," Serwer, who was not involved in the UCSF research, told Fox News Digital. The study did have some limitations. "Variability in cannabis strains complicates standardization," the researchers wrote. "Self-reported cannabis use may introduce recall bias; thus, participants were queried at multiple points: in the online survey, at the eligibility interview and before each visit." It was also challenging to determine whether blood vessel function could have also been affected by lifestyle factors like stress, caffeine and secondhand smoke exposure, they noted. Serwer pointed out that this was a "very small" study of only 55 people, all living in the San Francisco Bay area. "The study did not allow for variability in the different strains of cannabis, and they used a self-reporting survey, which can be under- or over-reported," he told Fox News Digital. "They looked for physiologic endpoints and not hard endpoints, such as heart attacks, strokes or death. We have to infer that the physiologic endpoints would result in cardiovascular events." Click Here To Sign Up For Our Health Newsletter The cardiologist said he agreed, however, with the conclusion that cannabis use is "not benign." "Chronic use does have potential cardiovascular risks," he warned. "There are therapeutic uses of cannabis, and the decision to use or avoid it should be made with all benefits and risks in mind." In general, Serwer said he cautions all of his patients to avoid any unnecessary cardiac risks. "As clinicians, we must weigh the benefits and the risks of a medicine/drug or intervention," he said. "If the risks outweigh the benefits, it should be avoided." For more Health articles, visit The study was funded mainly by the National Institute on Drug Abuse; the California Department of Cannabis Control; the California Tobacco-Related Disease Program; the National Heart, Lung, and Blood Institute; and the FDA Center for Tobacco Products. Fox News Digital reached out to cannabis industry organizations requesting article source: Smoking marijuana and eating cannabis gummies both linked to dangerous health risk, study finds

Yahoo
2 hours ago
- Yahoo
TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy
BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company" or 'TRX'), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ('Ucare'), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ('VitaCare') have entered into a share exchange agreement (the 'Agreement') with certain shareholders (the 'Sellers') of Ucare and other parties. Under the Agreement, the Sellers will receive 101,486,575 newly-issued class A ordinary shares ('Shares') of TRX, each with a par value of US$0.025. The number of Shares is calculated based on the weighted average closing price of TRX's Class A ordinary shares over the three months preceding the Agreement, at a per-share price of US$1.478. The Shares will represent approximately 91.75% of the Company's total issued and outstanding Class A ordinary shares and approximately 13.70% of its total voting power upon closing, which is subject to customary conditions. Ucare develops innovative healthcare solutions that enable providers, payers, and institutions to reduce fraud, abuse, waste, and administrative costs. Powered by the largest hospital database, Ucare's cloud-based generative AI platform continuously refines disease models by integrating real-world data, the latest medical guidelines, and real-time intelligence. Ucare's vision is to ease the burden on patients, expand coverage, and ultimately improve access to healthcare for everyone. It currently serves over 4,000 hospitals and has contributed an estimated US$6.82 billion reduction in avoidable healthcare expenditures as of December 2024. For the fiscal year ended October 31, 2024, Ucare reported a net profit of US$0.6 million on revenues of US$5.4 million. This acquisition comes at a time when China's health insurance market is rapidly expanding to complement national health coverage reforms. By integrating Ucare's AI-driven data analytics, institutional channels, and clinical treatment guidance tools, TRX aims to build differentiated health insurance products, strengthen their distribution within hospital systems, and accelerate its transition into a data-powered, platform-based insurance service provider. The transaction is expected to close on or about July 2025. Shares issued to the Sellers will be held in escrow and released based on Ucare achieving a cumulative revenue target of at least RMB150 million over the three years following closing. Post-transaction, Ucare will operate as a wholly-owned subsidiary of VitaCare. Key Ucare management, including Chief Executive Officer Mr. Wei Zhu, will remain in their roles to drive continuity and growth. Mr. Wei Zhu, Chief Executive Officer of Ucare, stated, 'We are excited to join forces with TRX in a transaction that validates our mission and achievements. Over the years, we've built China's leading hospital management platform, powered by proprietary AI algorithms and a deep understanding of healthcare system dynamics. TRX's platform, capital access, and industry network will empower us to scale R&D, integrate the latest generative AI into clinical pathways, and expand our offerings from medical institutions to insurance companies. This marks a pivotal moment in building a unified ecosystem that brings hospitals, insurers, and patients closer together for more efficient, transparent healthcare.' Ms. Sheng Xu, Director, Chairwoman and Chief Executive Officer of TRX, commented, 'This Agreement with Ucare represents a critical acquisition that expands our business channels by adding health insurance offerings that complement our property insurance products. With its unique positioning and first-mover advantage as the sole provider of cloud-based AI solutions for health insurance risk management, Ucare gives us privileged access to healthcare data, decision-makers, and patient journeys. This will significantly enhance our ability to design tailored insurance products,recommend solutions, streamline claims and diversify revenues. We view Ucare not only as a growth engine but as a strategic hub that bridges insurance services with healthcare delivery—an integration we believe will define the next decade of our industry.' About TIAN RUIXIANG Holdings LtdTIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker operating in China through its China-based variable interest entity. It distributes a wide range of insurance products, which are categorized into two major groups: (1) property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and (2) other types of insurance, such as health insurance, life insurance, and other miscellaneous insurance. About Ucare Inc. develops innovative healthcare solutions that enable providers, payers, and institutions to reduce fraud, abuse, waste, and administrative costs. Powered by the largest hospital database, Ucare's cloud-based generative AI platform continuously refines disease models by integrating real-world data, the latest medical guidelines, and real-time intelligence. Ucare's vision is to ease the burden on patients, expand coverage, and ultimately improve access to healthcare for everyone. Forward-Looking StatementsCertain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review risk factors that may affect its future results in the Company's registration statement and in its other filings with the U.S. Securities and Exchange Commission. For investor and media enquiries, please contact:TIAN RUIXIANG Holdings LtdInvestor Relations DepartmentEmail: ir@ Water Tower ResearchFeifei ShenEmail: feifei@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data